Cogent Biosciences Inc (COGT)
39.97
+2.02%
Cogent Biosciences Inc (COGT) is currently trading at $39.97. This represents a gain of 2.02% from the previous session. With a market capitalization of $6.47B, COGT is a key component of the Health Care sector. Investors looking to trade COGT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade COGT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Cogent Biosciences Inc (COGT) shows a bullish trend. Analysts are watching the 40.45 level closely.
Fundamentals
Mkt Cap6.47B
P/E Ratio0.0000
Volume1,899,080
60-Day Technical Chart
Advanced Charting
Need more indicators for COGT? Use the world's #1 platform.
Open COGT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $40
| Metric |
COGT +2.02% |
CMG +2.82% |
PPL +0.42% |
AXTI +16.79% |
|---|---|---|---|---|
| Price | $39.97 | $37.50 | $38.28 | $40.97 |
| Mkt Cap | $6.47B | $48.80B | $28.76B | $2.22B |
| - | View → | View → | View → |
Latest Headlines
Cogent Biosciences, Inc. $COGT Stock Position Cut by NEOS Investment Management LLC
MarketBeat • Feb 21, 2026
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire • Feb 17, 2026
Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed?
Yahoo Finance • Nov 12, 2025
Cogent (Nasdaq: COGT) commences $200M convertible notes due 2031 and stock offering
Stock Titan • Nov 10, 2025
Cogent Biosciences: Time For A Pause (NASDAQ:COGT)
Seeking Alpha • Dec 15, 2025
● Gemini Agentic AI Analyst Insight for COGT
Market Education
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
- I don't get this Dollar Cost Averaging (DCA). Explain pls Jul 18, 2023
- Long Short Strategy to Manage Risk May 31, 2024
External Research